FGen is an emerging Swiss biotech company active as a contract research organization in strain development and optimization. Key technologies are methods for biological engineering, such as Synthetic Biology or non-GMO methods, and a proprietary screening platform for high throughput screening. In 2022 was acquired by Ginkgo Bioworks.

Facts & figures
  • Type of organization
    Private company
  • Year of foundation
  • Number of employees in Switzerland